DMSO induced myocardial infarction during allogeneic cryopreserved bone marrow transplant

Ann Hematol. 2015 Mar;94(3):511-3. doi: 10.1007/s00277-014-2181-2. Epub 2014 Aug 20.

Authors

Mohamad Khawandanah¹, Sarah Hopps, Sobia Nabeel, Bilal Ahmad, Susan Weiss, Jennifer Holter Charkrabarty, Carrie Yuen, George Selby

Affiliation

¹ Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA, mohamad-khawandanah@ouhsc.edu.

PMID: 25135449
DOI: 10.1007/s00277-014-2181-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Bone Marrow Cells
Bone Marrow Transplantation / adverse effects*
Cryopreservation
Cryoprotective Agents / adverse effects*
Dimethyl Sulfoxide / adverse effects*
Glucosephosphate Dehydrogenase Deficiency / complications
Humans
Male
Myocardial Infarction / chemically induced*
Myocardial Infarction / diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Transplantation, Homologous

Substances

Cryoprotective Agents
Dimethyl Sulfoxide